A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...
36m
News Medical on MSNResearch highlights gender and age differences in eye gene therapy responsesOlder women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results